IGF2BP1 and bronchopulmonary dysplasia: According to Bao et al. (91), demonstrated that the expression of several m6A regulators—namely YTHDF1, YTHDF2, ZC3H13, FTO, ELAVL1, LRPPRC, RBM15B, METTL14, CBLL1, and FMR1—was down-regulated in the BPD cohort compared to controls, whereas the levels of IGF2BP1, IGF2BP2, and IGF2BP3 were found to be elevated (64).